A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema
- 31 October 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 116 (4), 876-883
- https://doi.org/10.1016/j.jaci.2005.05.019
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJournal of Allergy and Clinical Immunology, 2004
- N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbitsGlycobiology, 2003
- C1-Esterase Inhibitor Transfusions in Patients with Hereditary AngioedemaAnnals of Allergy, Asthma & Immunology, 1998
- Estimating impossible curves using NONMEMBritish Journal of Clinical Pharmacology, 1996
- Hereditary and Acquired C1-Inhibitor DeficiencyMedicine, 1992
- Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.Journal of Clinical Investigation, 1990
- Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.Journal of Clinical Investigation, 1986
- C1 INH Concentrate in the Therapy of Hereditary AngioedemaAllergy, 1983
- Replacement Therapy in Hereditary AngioedemaNew England Journal of Medicine, 1980
- Hereditary angioneurotic edema: II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikreinJournal of Allergy, 1962